Advances in the medical management of Cushing's syndrome

Francesca Pecori Giraldi, Francesco Cavagnini

Research output: Contribution to journalArticlepeer-review


Background: Management of Cushing's syndrome, that is, excess cortisol secretion, has undergone considerable advances since the pioneering studies by Harvey Cushing. Surgery is clearly first choice for all etiologies of Cushing's syndrome, and medical therapy is largely administered in the interim between other therapeutic options. The limited use of medical therapy is a consequence of the lack of a truly efficacious compound to restrain adrenocorticotrophic hormone or cortisol secretion, but this will hopefully change in the near future as molecules developed over the past few years are tested. Conclusion: This paper illustrates present and perspective medical treatments for Cushing's syndrome.

Original languageEnglish
Pages (from-to)2423-2433
Number of pages11
JournalExpert Opinion on Pharmacotherapy
Issue number14
Publication statusPublished - Oct 2008


  • ACTH
  • Bromocriptine
  • Cabergoline
  • Cortisol
  • Cushing's syndrome
  • Ketoconazole
  • Metyrapone
  • Mitotane
  • Pasireotide
  • Retinoic acid
  • Somatostatin
  • Somatostatin analogues
  • Steroidogenesis inhibitors
  • Thiazolidinediones

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'Advances in the medical management of Cushing's syndrome'. Together they form a unique fingerprint.

Cite this